<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01570010</url>
  </required_header>
  <id_info>
    <org_study_id>Norwegian Foods Study</org_study_id>
    <secondary_id>2011/836</secondary_id>
    <nct_id>NCT01570010</nct_id>
  </id_info>
  <brief_title>Effect of the New Norwegian Food Based Dietary Guidelines on Chronic Diseases in Colorectal Cancer Survivors</brief_title>
  <acronym>NFS</acronym>
  <official_title>Effect of the New Norwegian Food Based Dietary Guidelines on Chronic Diseases in Colorectal Cancer Survivors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oslo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute for Health and Welfare, Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Akershus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Asker &amp; Baerum Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sykehuset Buskerud HF</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Norwegian Cancer Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Research Council of Norway</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Oslo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study to examine whether an intensive dietary intervention affects health
      measures and development of lifestyle diseases in colorectal cancer survivors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The increased incidence and survival after treatment contributes to a rising number of people
      living with a previous cancer diagnosis. Cancer-survivors have an increased risk of
      developing other lifestyle diseases compared to an age-mathed general population. The aim of
      this study to examine whether a dietary changes affects health and development of lifestyle
      diseases after treatment for colorectal cancer. The diet in the study is based on the new
      Norwegian food-based dietary guidelines, and in addition focus is placed on foods which have
      been shown to inhibit inflammation or oxidative stress in epidemiological and experimental
      studies, as well as Norwegian and Nordic foods. The dietary intervention is combined with
      intensive follow-up to ensure high compliance to the diet.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">March 2040</completion_date>
  <primary_completion_date type="Anticipated">March 2040</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in biomarkers of comorbid conditions over the intervention period</measure>
    <time_frame>0, 6 and 12 months</time_frame>
    <description>Including but not limited to: blood pressure, LDL-/HDL-/VLDL-/oxLDL-/totalcholesterol, cholesterol efflux, triglyserides, HbA1c, blood sugar, BMI, body composition, waist and hip circumference, CEA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in biomarkers of inflammation and oxidative stress from baseline to 6 and 12 months</measure>
    <time_frame>0, 6 and 12 months</time_frame>
    <description>Including but not limited to: CRP, interleukines/chemokines, isoprostanes, GSH:GSSG, FRAP, dROM</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Compliance to intervention up to 12 months</measure>
    <time_frame>0, 6, and 12 months</time_frame>
    <description>Compliance to the intervention tested via biomarkers in blood such as carotenoids and fatty acids profiles, and via self reporting in questionnaires</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in physical function over the first 12 months</measure>
    <time_frame>0, 6, and 12 months</time_frame>
    <description>Submaximal oxygen test, grip strenght and physical activity level</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in dietary patterns during first 12 months</measure>
    <time_frame>0, 6 ,and 12 months</time_frame>
    <description>Questionnaires, biomarkers of dietary intake and food diaries</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>up to 15 years</time_frame>
    <description>All-cause mortality, diet-related chronic diseases (a priori defined), deaths attributed to cardiovascular diseases, cancers and non CVD-, non-cancer-, inflammatory diseases</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>colorectal cancer-free survival and disease-free survival</measure>
    <time_frame>up to 15 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue and quality of life</measure>
    <time_frame>0, 0.5, 1, 3, 5, 7, 10 and 15 years</time_frame>
    <description>Questionnaires</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarkers of thromboembolic disease</measure>
    <time_frame>0, 0.5, 1, 3, 5, 7, 10 and 15 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>25 hydroxy vitamin D</measure>
    <time_frame>0, 0.5, 1, 3, 5, 7, 10 and 15 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>whole genome transcription profiles and methylation patterns</measure>
    <time_frame>0, 0.5, 1, 3, 5, 7, 10 and 15 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Co-morbidity</measure>
    <time_frame>0.5, 1, 3, 5, 7, 10, 15 years</time_frame>
    <description>Including but not limited to cardiovascular diseases, diabetes, recurring cancer, incident cancers, etc</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in biomarkers of comorbid conditions compared to baseline</measure>
    <time_frame>3, 5, 7, 10 and 15 years</time_frame>
    <description>Including but not limited to: blood pressure, LDL-/HDL-/VLDL-/oxLDL-/totalcholesterol, cholesterol efflux, triglyserides, HbA1c, blood sugar, BMI, body composition, waist and hip circumference, CEA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in biomarkers of inflammation and oxidative stress</measure>
    <time_frame>0, 3, 5, 7, 10 and 15 years</time_frame>
    <description>Including but not limited to: CRP, interleukines/chemokines, isoprostanes, GSH:GSSG, FRAP, dROM</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Continued ompliance to intervention during follow up</measure>
    <time_frame>up to 15 years</time_frame>
    <description>Compliance to the intervention tested via biomarkers in blood such as carotenoids and fatty acids profiles, and via self reporting in questionnaires</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in physical function up to 15 years</measure>
    <time_frame>0, 3, 5, 7, 10 and 15 years</time_frame>
    <description>Submaximal oxygen test, grip strenght and physical activity level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in dietary patterns up to 15 years</measure>
    <time_frame>0, 3, 5, 7, 10 and 15 years</time_frame>
    <description>Questionnaires, biomarkers of dietary intake and food diaries</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Counseling on physical activity only</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>new norwegian food based dietary guidelines</intervention_name>
    <description>several means will be applied to guide participarts to cohere to the dietary guidelines including access to clinical nutritionists, free food, food discounts, cooking courses, cookbook/recipies, study website, organized physical activity, etc</description>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
    <other_name>Typisk norsk</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  colorectal cancer (ICD10 C18-20) TNM Stage I-III

        Exclusion Criteria:

          -  TNM stage 0 or IV
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rune Blomhoff, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oslo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rune Blomhoff, PhD</last_name>
    <phone>+4722851395</phone>
    <email>rune.blomhoff@medisin.uio.no</email>
  </overall_contact>
  <location>
    <facility>
      <name>Vestre Viken Hospital</name>
      <address>
        <city>Sandvika</city>
        <state>Akershus</state>
        <country>Norway</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rune Blomhoff, Proff</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vestre Viken HF</name>
      <address>
        <city>Drammen</city>
        <state>Buskerud</state>
        <country>Norway</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rune Blomhoff, Prof.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Akershus University Hospital</name>
      <address>
        <city>Lørenskog</city>
        <zip>1478</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Færden, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Oslo</name>
      <address>
        <city>Oslo</city>
        <zip>0316</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Rune Blomhoff, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Smeland, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2012</study_first_submitted>
  <study_first_submitted_qc>March 30, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2012</study_first_posted>
  <last_update_submitted>December 4, 2015</last_update_submitted>
  <last_update_submitted_qc>December 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Oslo</investigator_affiliation>
    <investigator_full_name>Rune Blomhoff</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Chronic Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

